GSD-33264-36037
4 vaccinations
4 coded responses
29 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 494 / MI
- Registered
- 2021-11-24
- Relationship
- Self
- Race
- Other
- Ethnicity
- N/A
Registered dependents
58Y-29093-87020
Child or adolescent in my care · Male · 2021-11-24
YZN-16407-69208
Child or adolescent in my care · Female · 2021-11-24
8KY-54688-27629
Child or adolescent in my care · Female · 2021-11-24
Timeline
-
2021-04-02
Dose 1 — Pfizer-BioNTech
-
2021-04-26
Dose 2 — Pfizer-BioNTech
-
2021-11-24
Registered in v-safe
-
2021-11-24
Dose 3 — Moderna
- 2021-11-24
-
2021-11-25
Survey response — days 1–6 daily, dose 3MedDRA: Decreased appetite — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tirednessFree text: Low appetiteMedDRA releases: 2024-11 · check-in free text available
- 2021-11-26
- 2021-11-27
- 2021-11-28
- 2021-11-29
- 2021-11-30
- 2021-12-01
- 2021-12-08
- 2021-12-15
- 2021-12-24
-
2021-12-29
Survey response — day 35, dose 3MedDRA: Respiratory tract congestion, SARS-CoV-2 test negative, Throat irritation — Feeling: GoodFree text: Had several days of a scratchy throat and mild congestion in the last week. Tested negative for Covid on antigen and NAAT tests 2 days apart.MedDRA releases: 2024-11 · check-in free text available
- 2022-01-05
- 2022-02-23
- 2022-05-25
-
2022-11-03
Dose 4 — Pfizer-BioNTech
- 2022-11-03
-
2022-11-04
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Abdominal painAdult check-in
-
2022-11-05
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Redness · Muscle or body achesAdult check-in
- 2022-11-06
- 2022-11-08
- 2022-11-09
- 2022-11-12
-
2022-11-17
Survey response — day 14, dose 4MedDRA: Oropharyngeal pain — Feeling: GoodFree text: Sore throat beginning 11/16MedDRA releases: 2024-11 · check-in free text available
- 2022-11-24
- 2022-12-01
- 2022-12-08
- 2022-12-15
- 2023-02-03
-
2023-05-04
Survey response — 6 months, dose 4MedDRA: Oropharyngeal pain — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-02 | Pfizer-BioNTech | No |
| 2 | 2021-04-26 | Pfizer-BioNTech | No |
| 3 | 2021-11-24 | Moderna | No |
| 4 | 2022-11-03 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Low appetite
Release 10 — day 35, dose 3
Symptoms: Had several days of a scratchy throat and mild congestion in the last week. Tested negative for Covid on antigen and NAAT tests 2 days apart.
Release 12 — day 14, dose 4
Symptoms: Sore throat beginning 11/16
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Throat irritation | · | · | ✓ |
| SRO | Decreased appetite | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release